Literature DB >> 1916517

Changing concepts in the management of vulvar cancer.

G M Thomas1, A J Dembo, S C Bryson, R Osborne, A D DePetrillo.   

Abstract

Vulvar carcinoma varies widely in its clinical presentations and prognosis. The reviewed literature outlines the achievements of conventional surgery, radiation, or chemoradiation therapy in its management. Currently therapeutic concepts are evolving. New treatment strategies replacing the uniform use of radical vulvectomy and bilateral groin dissection are proposed. These strategies are tailored to the clinical and pathological disease extent and location and integrate the possible therapeutic advantages of both surgery and chemoradiation. The testing and use of the proposed multimodality therapy protocols require the expertise of gynecologic, radiation, and medical oncologists. This approach should lead to improved anatomic and functional preservation in early disease and improved locoregional in advanced disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916517     DOI: 10.1016/0090-8258(91)90223-r

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

Review 1.  "Unresectable" vulval cancers: is neoadjuvant chemotherapy the way forward?

Authors:  Kathryn Graham; Kevin Burton
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

2.  Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Authors:  A Gaudineau; D Weitbruch; P Quetin; S Heymann; T Petit; P Volkmar; F Bodin; M Velten; J F Rodier
Journal:  Oncol Lett       Date:  2012-07-27       Impact factor: 2.967

3.  Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article.

Authors:  Yizhen Niu; Rutie Yin; Danqing Wang; Qingli Li; Xiu Gao; Meimei Huang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  [Vulvar squamous cell carcinoma in a HIV-1 infected patient with first-line antiretroviral therapy failure].

Authors:  Alassane Dièye; Bruce Wembulua Shinga; Jacques Noel Tendeng; Moustapha Diedhiou; Birame Seck; Abdourahmane Ndong; Ndèye Méry Dia-Badiane
Journal:  Pan Afr Med J       Date:  2020-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.